||||||||||TQB2934 / Sino Biopharm Enrollment open, IO biomarker: A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects (clinicaltrials.gov) - May 9, 2023 P1, N=140, Recruiting, Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting --> Recruiting